Comparison of the Freiburg and Charlson Comorbidity Indices in Predicting Overall Survival in Elderly Patients with Newly Diagnosed Multiple Myeloma

<table>Kaplan-Meier survival curves of comorbidity index score groups. OS according to FCI in patients aged 65–74 years.</table>

BioMed Research International

fig2

Figure 2

Figure 2: Comparison of the Freiburg and Charlson Comorbidity Indices in Predicting Overall Survival in Elderly Patients with Newly Diagnosed Multiple Myeloma 

Figure 2 | Comparison of the Freiburg and Charlson Comorbidity Indices in Predicting Overall Survival in Elderly Patients with Newly Diagnosed Multiple Myeloma 